Oral administration of the small molecule cathepsin S inhibitor LY3000328 accelerates disease onset and impairs glucose tolerance in non-obese diabetic mice

Abstract



Original languageEnglish
Article number210
JournalDiabetologia
Volume65
Issue numberSUPPL 1
Pages (from-to)S109-S110
Number of pages1
ISSN0012-186X
Publication statusPublished - 31 Aug 2022
Event58th EASD Annual Meeting of the European Association for the Study of Diabetes - Stockholm, Sweden
Duration: 19 Sept 202223 Sept 2022

Conference

Conference58th EASD Annual Meeting of the European Association for the Study of Diabetes
Country/TerritorySweden
CityStockholm
Period19/09/202223/09/2022

Cite this